Accelerate portfolio expansion through competitive intelligence
From the very beginning, innovation has been a core element of Merz ́s corporate culture and strategic direction. Through the Merz Corporate Venture Capital
Initiative, Merz is offering partnering and supporting a company or technology across all of Merz‘s focus areas. In 2020, Merz created three independent businesses: Merz Aesthetics, Merz Therapeutics and Merz Consumer Care. The new structure will allow for more specialized customer focus and will increase operational agility and speed to market. The creation of three separate businesses is expected to continue fuelling the strong growth.
The Technology Scouting and External Innovation Teams at Merz Therapeutics are responsible for establishing and evaluating the competitive landscape of the current product portfolio. Which new products and companies have entered the market? Which emerging technologies could be used to further grow the portfolio?
Since 2018, technology scouting has been supported by ITONICS‘ tools to more transparently gather and evaluate insights on activities in the business environment
in order to make informed decisions to expand the company‘s portfolio.
products & companies
news & clinical trials
Merz Therapeutics Tech Scouting Process
The ITONICS Innovation Platform supports us in scouting new technologies and products for our pipeline. The huge amounts of data generated in this process are easily searchable for the colleagues involved and can be supplemented and evaluated together.
- Dr. Maarten Ruitenberg, Head of Technology Scouting & Operations, Merz Therapeutics
The ITONICS Innovation Platform allows to easily share information about external innovation opportunities across departments and countries. By being able to use a single system for data search (including search routines), storage and sharing, interdisciplinary evaluation teams are empowered to quickly review and assess opportunities.
Learn more about how innovative companies implemented a world-class innovation ecosystem!
Merz Therapeutics is part of the Merz Group, a family-owned company founded in 1908 by the pharmacist and chemist Friedrich Merz in Frankfurt,
Germany. Merz Therapeutics set itself the goal to improve patients’ health - bringing better outcomes to more patients.
Share this story